US EditionPublished • loading... • Updated
A Case for Full Disclosure: Two Drugs, Two Women, Only One Survived – Patient Worthy
Summary by Patient Worthy
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A Case for Full Disclosure: Two Drugs, Two Women, Only One Survived – Patient Worthy
Sixty-five-year-old JoEllen Zembruski-Ruple had been a cancer patient at the revered Sloan Kettering center in January of this year. Her treatment for squamous cell carcinoma began with three chemotherapy pills. According to JoEllen’s family no one realized at the time that the drug would eventually kill her as it has been known to kill almost […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
